nauseous after semaglutide shot How to Avoid Sickness While Taking Ozempic Side Effects: How Long

Nat Med 22(8):879888

FDA Telehealth Warning Letters In early March 2026, the FDA reportedly issued warning letters to multiple telehealth companies regarding compounded GLP-1 marketing practices, with concerns including misleading marketing claims, implications of equivalence with FDA-approved drugs, and obscuring product sourcing

A healthcare provider will review your medical history, current health status, and goals to determine if tirzepatide is the right path for you

I thought it was an inappropriate way to sell a fairly serious product. Following the FDA warning letter, LifeVantage appeared to lean more heavily on disclaimers that its products are not intended to diagnose, treat, cure or prevent any disease, and instructed its distributors to do the same